1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Syringes, Needles and Urinary Catheters Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Syringes, Needles and Urinary Catheters Market, United States
3.1 Syringes, Needles and Urinary Catheters Market, United States, Revenue ($m), 2018-2033
3.1.1 Urinary Catheters Market, United States, Revenue ($m), by Segment, 2018-2033
3.2 Syringes, Needles and Urinary Catheters Market, United States, Volume (Units), 2018-2033
3.2.1 Urinary Catheters Market, United States, Volume (Units), by Segment, 2018-2033
3.3 Syringes, Needles and Urinary Catheters Market, United States, Average Price ($), 2018-2033
3.4 Syringes, Needles and Urinary Catheters Market, United States, Distribution Share by Revenue ($m), 2023
3.5 Syringes, Needles and Urinary Catheters Market, United States, Company Share by Revenue ($m), 2023
4 Overview of Key Companies in United States, Syringes, Needles and Urinary Catheters Market
4.1 Becton Dickinson and Co
4.1.1 Company Overview
4.2 Cardinal Health Inc
4.2.1 Company Overview
4.3 Stryker Corp
4.3.1 Company Overview
4.4 Medline Industries LP
4.4.1 Company Overview
4.5 Avanos Medical Inc
4.5.1 Company Overview
6 Financial Deals Landscape
6.1 Asset Transactions
6.1.1 Sharps Technology to Acquire InjectEZ Specialty Syringe Manufacturing Assets from Nephron Pharma for USD35 Million
6.2 Debt Offerings
6.2.1 Zimmer Biomet Holdings Prices USD743.76 Million in Public Offering of 3.518% Notes Due 2032
7 Recent Developments
7.1 Corporate Communications
7.1.1 Oct 02, 2024: PharmaJet Names Wouter Latour as Chief Executive Officer
7.1.2 Feb 28, 2024: Bob Azelby to Join Cardinal Health Board of Directors
7.2 Financial Announcements
7.2.1 Nov 01, 2024: Cardinal Health Announces Q1 Fiscal Year 2025 Results
7.2.2 Oct 10, 2024: BD to Announce its Fiscal 2024 Fourth Quarter and Full Year Financial Results
7.2.3 Oct 09, 2024: Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2024 Financial Results
7.2.4 Oct 08, 2024: Merit Medical Systems to Announce Third Quarter 2024 Results on October 30, 2024
7.2.5 Aug 14, 2024: Cardinal Health Reports Fourth Quarter and Fiscal Year 2024 Results and Raises Fiscal Year 2025 Guidance
7.2.6 Aug 07, 2024: Zimmer Biomet Announces Second Quarter 2024 Financial Results
7.2.7 Aug 01, 2024: Merit Medical Systems Announces Q2 2024 Results and Raises Full-Year Guidance
7.2.8 Aug 01, 2024: Axonics Reports Second Quarter 2024 Financial Results
7.2.9 Jul 03, 2024: BD to Announce Financial Results for its Third Quarter of Fiscal 2024
7.2.10 Jun 18, 2024: Merit Medical Systems to Announce Second Quarter 2024 Results on August 1, 2024
7.3 Government and Public Interest
7.3.1 Dec 01, 2023: Retractable Technologies Not Impacted by FDA Safety Communication
7.3.2 Dec 01, 2023: Sol-Millennium Responds to FDA Safety Communication
7.4 Legal And Regulatory
7.4.1 Apr 24, 2024: WARNING LETTER : Cardinal Health 200 LLC
7.4.2 Mar 21, 2024: Sol-Millennium Responds to FDA’s Warning Letter and Safety Communication
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 the analyst Consulting
8.3 Contact the Publisher
8.4 Disclaimer
List of Tables
Table 1: Syringes, Needles and Urinary Catheters Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 2: Urinary Catheters Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 3: Syringes, Needles and Urinary Catheters Market, United States, Volume (Units), 2018-2033
Table 4: Urinary Catheters Market, United States, Volume (Units), 2018-2033
Table 5: Syringes, Needles and Urinary Catheters Market, United States, Average Price ($), 2018-2033
Table 6: Syringes, Needles and Urinary Catheters Market, United States, Distribution Share by Revenue ($m), USD Constant, 2023
Table 7: Syringes, Needles and Urinary Catheters Market, United States, Company Share by Revenue ($m), USD Constant, 2023
Table 8: Syringes, Needles and Urinary Catheters Market Pipeline Products
Table 9: Sharps Technology to Acquire InjectEZ Specialty Syringe Manufacturing Assets from Nephron Pharma for USD35 Million
Table 10: Zimmer Biomet Holdings Prices USD743.76 Million in Public Offering of 3.518% Notes Due 2032
Table 11: Total Number of Primary Research Participants, Hospital Supplies Market, by Country
List of Figures
Figure 1: Syringes, Needles and Urinary Catheters Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 2: Urinary Catheters Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 3: Syringes, Needles and Urinary Catheters Market, United States, Volume (Units), 2018-2033
Figure 4: Urinary Catheters Market, United States, Volume (Units), 2018-2033
Figure 5: Syringes, Needles and Urinary Catheters Market, United States, Company Share (%) 2023
